Shares of Hospira (HSP) tumbled 2.81% to close the trading session on Aug 19 at $53.92 per share, following the company’s decision to file a lawsuit against the FDA over approvals granted to generic ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Hospira Inc. is suing fellow pharma manufacturer Akorn Inc ...

After a bench trial, the US District Court for the District of Delaware found several Hospira patents covering a diluted, “ready-to-use” composition of dexmedetomidine obvious in view of the ...

Dexmedetomidine HCl in 0.9% NaCl; 4mcg/mL; soln for IV infusion. Precedex (dexmedetomidine hydrochloride) injection 200 mcg/2 mL (100 mcg/mL) is clear and colorless. The strength is based on the ...

To earn CME related to this news article, click here. January 2, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions for clofarabine injection, dexmedetomidine HCl ...

Add Yahoo as a preferred source to see more of our stories on Google. By Brendan Pierson (Reuters) - A federal judge has issued a temporary restraining order against the U.S. Food and Drug ...

Hospira's reprieve from generic Precedex competition was short-lived. The U.S. district court that temporarily stopped Precedex generics has now decided to let the copycats roll. And that could mean ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. (AP) — Drug and medical device maker Hospira Inc. said ...

Orion Corporation and Hospira, Inc. have extended their licensing agreement concerning the sedative agent Precedex® in the markets outside the Europe. Orion and Hospira (originally Abbott) have ...

Dr. Reddy’ is offering dexmedetomidine hydrochloride in 0.9% sodium chloride injection. The product is the generic of Hospira’s Precedex (dexmedetomidine hydrochloride) in 0.9% Sodium Chloride ...

The FDA has approved Precedex (dexmedetomidine HCl, from Hospira) injection for the sedation of non-intubated patients prior to and/or during surgical and other procedures. This approval is based on ...

Shares of Hospira ( HSP) tumbled 2.81% to close the trading session on Aug 19 at $53.92 per share, following the company's decision to file a lawsuit against the FDA over approvals granted to generic ...